Company Information
About Ixion
Products
Management expand tree
Financial Info
Shareholder Info expand tree
SEC/Finance Reports
Target Diseases
  Diabetes General Information
  Diabetes FAQ's
  Diabetes Economic Impact
  Diabetes Product Plan
  Diabetes Questions/Comments
  Kidney Stones
  Cystic Fibrosis
  Crohn's Disease
  Primary Hyperoxaluria
  Idiopathic Hyperoxaluria
  Vulvodynia
  Catheters & Stents
Questions/Comments

  Aspergillosis
  Companion (Animal)
Inside Ixion
          Scientific Articles
          Intellectual Property
Newsroom
          2003
          2002
          2001
Contact Us
   Online Form/Contact Info
   Directions & Map
Home 
Overview of Catheters and Stents


        We are developing an oxalate-resistant urinary catheter with funds received under an SBIR grant. Stents and catheters often foster infection and account for the leading side effect of an invasive hospital procedure. One major cause of urinary device infection is encrustation by oxalate crystals on the stent and catheter and subsequent bacterial adhesion. Such devices are also often occluded by oxalate crystals, requiring replacement.

        There are approximately one million catheter-associated urinary tract infections that occur each year (involving 10-30% of patients with in-dwelling catheters). Although use of anti-microbial coatings and materials is growing, no anti-oxalate catheter exists.